Main Article Content

Abstract

Drug management is part of pharmaceutical service activities, which includes interrelated stages: selection, planning, requesting, receiving, storage, distribution, controlling, recording, reporting, monitoring and evaluation, which play an essential role in ensuring the availability of drugs at PHCs. The systematic review aims to identify indicators of drug management at PHCs in Indonesia and analyze factors that influenced it. This systematic review used the PRISMA methods. Google Scholar is an electronic database to identify related studies. This study is limited publications from 2013 to 2023. The quality of the articles was assessed using JBI Critical Appraisal. The electronics database search earned 570 articles, while only nine articles met the criteria for analysis. Several indicators are different from the standards used due to several factors. Based on the result, factors influencing drug management at PHCs include human resources, financing, information management, facilities, and technology. For most of them, human resources are a determining factor that significantly influences the quality of pharmaceutical services at PHC’s in Indonesia. The implementation of pharmaceutical services at the PHCs must be carried out by at least one pharmacist, the person in charge, who can be assisted by pharmaceutical technical staff as needed. Resources humans influence indicators of planning accuracy; suitability of requests; storage; distribution; control; recording, reporting, and archiving. This study's results are to make improvement strategies, including interventions to improve the quality of pharmaceutical services that impact community satisfaction and stakeholders.

Keywords

Drug management Primary health center Factor influencing

Article Details

References

  1. Anisah, N., Yunita, S. L., & Hidayati, I. R. (2023). Analisis Pengelolaan Obat di Puskesmas X Provinsi Kalimantan Selatan. Journal Syifa Sciences and Clinical Research, 5(1), 71–80.
  2. Carolien, I., Fudholi, A., & Endarti, D. (2017). Evaluasi Ketersediaan Obat Sebelum dan Sesudah Implementasi JKN di Kabupaten Keerom Papua. Jurnal Manajemen dan Pelayanan Farmasi, 7(1), 30–39. https://doi.org/10.22146/jmpf.30294
  3. Chaira, S., Zaini, E., & Augia, T. (2016). Evaluasi Pengelolaan Obat pada Puskesmas di Kota Pariaman. Jurnal Sains Farmasi & Klinis, 3(1), 35–41. https://doi.org/10.29208/jsfk.2016.3.1.97
  4. Cholilah, Wijayanti, T., & Satibi, (2021). Analisis Mutu Pengelolaan Obat di Puskesmas Kota Tegal. Jurnal Manajemen dan Pelayanan Farmasi, 11(4), 274–285. https://doi.org/10.22146/jmpf.69095
  5. George, P. P., Molina, J. A. D., & Heng, B. H. (2014). The methodological quality of systematic reviews comparing intravitreal bevacizumab and alternates for neovascular age related macular degeneration: A systematic review of reviews. Indian Journal of Ophthalmology, 62(7), 761–767. https://doi.org/10.4103/0301-4738.138615
  6. Joanna Briggs Institute. (2022). JBI Critical Appraisal Tools. Joanna Briggs Institute.https://jbi.global/critical-appraisal-tools.
  7. Marathe, S., Sardeshpande, N., & Yakkundi, D. (2015). What Causes Medicine Shortages in Primary Health Centers?: A Case Study of Availability and Supply System of Medicines in Select PHCs from Maharashtra. Journal of Health Management, 17(1), 86–97. https://doi.org/10.1177/0972063414560873
  8. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. The BMJ, 372(n71). https://doi.org/10.1136/bmj.n71
  9. Rezeki, A., Fhory, B. N., Yasa, M. S. R., Syahriah, & Wathan, N. (2021). Evaluasi ketersediaan obat di beberapa puskesmas wilayah kabupaten X tahun 2019. Sasambo Journal of Pharmacy, 2(2), 65–72. https://doi.org/10.29303/sjp.v2i2.120
  10. RI Ministry of Health. (2019). Peraturan Menteri Kesehatan Republik Indonesia Nomor 43 Tahun 2019, tentang Pusat Kesehatan Masyarakat.
  11. Rintanantasari, Fudholi, A., & Satibi. (2021). Evaluasi Perencanaan dan Pengendalian Obat di Puskesmas Wilayah Kabupaten Tulungagung dan Kota Kupang. Majalah Farmaseutik, 17(3), 296–302.
  12. Sariah, Fernanda, Y., Annisa, R., & Wathan, N. (2022). Evaluasi Pengelolaan Obat di Puskesmas Terminal Kota Banjarmasin Tahun 2021. Borneo Journal of Pharmascientech, 06(02), 86–93.
  13. Satibi, Daulay, E. H., Oviani, G. A., Erlianti, K., Fudholi, A., & Puspandari, D. A. (2018). Analisis Kinerja Apoteker dan Faktor Yang Mempengaruhi Pada Era Jaminan Kesehatan Nasional di Puskesmas. Jurnal Manajemen dan Pelayanan Farmasi, 8(1), 32–38.
  14. Satibi, Prasetyo, S. P., Rokhman, M. R., & Aditama, H. (2021). Penilaian Mutu Pelayanan Kefarmasian di Puskesmas. UGM Press, Yogyakarta.
  15. Tawfik, G. M., Dila, K. A. S., Mohamed, M. Y. F., Tam, D. N. H., Kien, N. D., Ahmed, A. M., & Huy, N. T. (2019). A step-by-step guide for conducting a systematic review and meta-analysis with simulation data. Tropical Medicine and Health, 47(1), 46. https://doi.org/10.1186/s41182-019-0165-6
  16. Tualeka, U., Fudholi, A., & Satibi. (2021). Analisis Ketersediaan Obat di Puskesmas Kabupaten Maluku Tengah. Majalah Farmaseutik, 17(3), 303–311.
  17. Wibowo A., & Putri S. (2021). Pedoman Praktis Penyusunan Naskah Ilmiah dengan metode systematic review (1st ed.). Departemen Administrasi dan Kebijakan Kesehatan - Fakultas Kesehatan Masyarakat Universitas Indonesia. https://doi.org/10.13140/RG.2.2.17871.20640
  18. Yuswantina, R., Lestari, M. A., Aprilia, L., & Dyahariesti, N. (2022). Studi Pengelolaan Obat di Puskesmas Boja 1 Kabupaten Kendal Tahun 2020. Jurnal Ilmiah Manuntung, 8(2), 242–247.
  19. Zeng, X., Zhang, Y., Kwong, J. S. W., Zhang, C., Sheng, L., Feng, S., Yuming, N., & Liang, D. (2015). The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. Journal Evidence Based Medicine, 8(1), 2–10.